Close Menu

Neurological & Psychological Disorders

News on research and diagnostic developments in neuroscience.

Evogen's protein biomarker-based test is designed to stratify actively seizing patients from those who have not experienced a recent seizure.

The biomarkers — ubiquitin carboxyl terminal hydrolase-L1 and glial fibrillary acidic protein — can be detected in blood soon after a brain injury.

The researchers developed a plasma protein signature that can identify patients with cerebrospinal fluid amyloid-β42 levels indicative of risk for the disease.

The Army previously awarded Abbott $11.3 million to develop a TBI test. Abbott has worked with DoD since 2014 to develop tests to help evaluate potential concussions.

Free genetic testing on a broad gene panel is available to children, from birth to five years old, if they've had an unprovoked seizure.